VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 104 filers reported holding VERONA PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,983,237 | -22.9% | 6,317,990 | 0.0% | 2.03% | -19.6% |
| Q2 2023 | $133,562,309 | +5.3% | 6,317,990 | 0.0% | 2.52% | -12.2% |
| Q1 2023 | $126,865,239 | -23.2% | 6,317,990 | 0.0% | 2.87% | -14.2% |
| Q4 2022 | $165,089,079 | +167.0% | 6,317,990 | +4.4% | 3.35% | +153.8% |
| Q3 2022 | $61,831,000 | +189.3% | 6,050,000 | +18.6% | 1.32% | +131.4% |
| Q2 2022 | $21,369,000 | -16.0% | 5,100,000 | 0.0% | 0.57% | +2.7% |
| Q1 2022 | $25,449,000 | -25.7% | 5,100,000 | 0.0% | 0.56% | -8.1% |
| Q4 2021 | $34,272,000 | +22.6% | 5,100,000 | 0.0% | 0.60% | +56.1% |
| Q3 2021 | $27,948,000 | -16.2% | 5,100,000 | 0.0% | 0.39% | -27.7% |
| Q2 2021 | $33,354,000 | -21.8% | 5,100,000 | 0.0% | 0.54% | -16.8% |
| Q1 2021 | $42,636,000 | +34.0% | 5,100,000 | 0.0% | 0.64% | +44.5% |
| Q4 2020 | $31,824,000 | 0.0% | 5,100,000 | 0.0% | 0.44% | -23.5% |
| Q3 2020 | $31,824,000 | – | 5,100,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |